BXP — Beximco Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual balance sheet for Beximco Pharmaceuticals, fiscal year end - June 30th, BDT millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	BAS	BAS	BAS	BAS	BAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	675	1,169	1,136	1,054	2,600
Net Total Accounts Receivable
Net Total Receivables	3,574	3,894	4,261	4,251	4,363
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	13,771	18,419	20,876	20,818	23,786
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	36,531	42,379	42,808	43,049	44,027
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	52,246	66,148	69,157	69,344	73,247
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,350	12,736	13,265	9,562	8,393
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	15,216	25,548	25,476	21,394	20,140
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	37,031	40,600	43,681	47,950	53,107
Total Liabilities & Shareholders' Equity	52,246	66,148	69,157	69,344	73,247
Total Common Shares Outstanding